Search Results

3726 - 3750 of 75592
TitleWireDateTime
Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results Globe Newswire 05/05 08:00
VisionSys AI Inc Announces Planned ADS Ratio Change Globe Newswire 05/05 08:00
Global Indemnity Group, LLC Reports First Quarter 2026 Financial Results Globe Newswire 05/05 08:00
STACK Infrastructure Appoints Bobby Hollis as Chief Development Officer Globe Newswire 05/05 08:00
SHARC Energy Selected by National Laboratory of the Rockies for Advanced Wastewater Energy Recovery Project Globe Newswire 05/05 08:00
Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 Globe Newswire 05/05 08:00
Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates Globe Newswire 05/05 08:00
zSpace Expands Immersive Learning Footprint in Poland with New 3D STEM Laboratory at Bieruń High School Globe Newswire 05/05 08:00
Madrigal Adds Clinical-Stage siRNA Asset Targeting PNPLA3 to its MASH Pipeline Globe Newswire 05/05 08:00
[Latest] Digestive Health Supplements Market Size Expected to Reach USD 25.86 Billion by 2034 With 6.10% CAGR, Driven by Rising Geriatric Population Worldwide and Increasing Prevalence of Digestive Health Concerns Globe Newswire 05/05 07:59
Neuronetics Reports First Quarter 2026 Financial and Operating Results Globe Newswire 05/05 07:50
Jetterix Pressure Nozzle Re-Invesitigated In 2026 Globe Newswire 05/05 07:48
Rumble Announces Receipt of all Regulatory Approvals for Business Combination with Northern Data Globe Newswire 05/05 07:30
Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update  Globe Newswire 05/05 07:30
Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance Globe Newswire 05/05 07:30
Telesat reports results for the quarter ended March 31, 2026 Globe Newswire 05/05 07:30
Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy Globe Newswire 05/05 07:30
GD Culture Group Limited Announces Receipt of Preliminary Non-Binding Going Private Proposal at US$10.75 Per Share Globe Newswire 05/05 07:30
Kura Oncology to Report First Quarter 2026 Financial Results Globe Newswire 05/05 07:30
Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights Globe Newswire 05/05 07:30
BridgeBio to Present Primary Results from the Phase 3 CALIBRATE Trial at 2026 ECE Globe Newswire 05/05 07:30
Exodus Movement, Inc. to Announce First Quarter 2026 Results on May 12, 2026 Globe Newswire 05/05 07:25
Cipher Digital Provides First Quarter 2026 Business Update Globe Newswire 05/05 07:22
ArcelorMittal announces results of its General Meetings Globe Newswire 05/05 07:21
HII Reports First Quarter 2026 Results Globe Newswire 05/05 07:15
3726 - 3750 of 75592

News, Photo and Web Search